Golden Sun Health Technology Group Limited Announces Joint Venture to Enter the Cultural Tourism Market
Golden Sun Health Technology Group Limited Announces Joint Venture to Enter the Cultural Tourism Market
SHANGHAI, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the "Company" or "Golden Sun") (Nasdaq: GSUN), a provider of tutorial services in China, today announced that the Company, through its wholly-owned subsidiary Shanghai Golden Sun Gongyu Education Technology Co., Ltd. ("Gongyu"), has established a strategic joint venture (the "JV") named Shanghai Fuyang Cultural Tourism Development Co., Ltd. The JV marks a significant milestone in the Company's ongoing business transformation, aiming to capitalize on the rapidly growing cultural tourism sector in China. The move is expected to further diversify the Company's revenue streams while leveraging its years' expertise in education technology to create synergies within the JV.
上海,2024年8月29日(GLOBE NEWSWIRE)——中國教程服務提供商金太陽健康科技集團有限公司(前身爲金太陽教育集團有限公司(「公司」 或 「金太陽」)(納斯達克股票代碼:GSUN)今天宣佈,該公司已通過其全資子公司上海金太陽公育教育科技有限公司(「Gongyu」)成立戰略合資企業(「合資企業」)命名爲上海富陽文化旅遊發展有限公司。該合資企業標誌着公司正在進行的業務轉型中的一個重要里程碑,旨在利用中國快速增長的文化旅遊業。此舉預計將進一步分散公司的收入來源,同時利用其多年的教育技術專業知識在合資企業內部創造協同效應。
On August 15, 2024, the Board of Directors of Gongyu unanimously approved an investment to establish the JV, partnering with two individuals who bring profound academic backgrounds, along with extensive experience and resources in designing over a hundred cultural tourism projects across China. The JV will focus on planning, design, consulting, and promotion services for cultural tourism projects and products, as well as the development and management of cultural and tourism resources. Gongyu agrees to invest and secure a 51% equity interest in the JV, with one of the partners designated to assume the role of executive director of the JV.
2024 年 8 月 15 日,Gongyu 董事會一致批准了成立合資公司的投資,該合資企業與兩位具有深厚學術背景的人士合作,在設計中國一百多個文化旅遊項目方面擁有豐富的經驗和資源。該合資企業將專注於文化旅遊項目和產品的規劃、設計、諮詢和推廣服務,以及文化和旅遊資源的開發和管理。Gongyu同意投資並獲得該合資企業51%的股權,並指定其中一位合夥人擔任該合資企業的執行董事。
Mr. Xueyuan Weng, Chairman and Chief Executive Officer of the Company, commented, "Amidst the booming growth of China's domestic tourism market especially in the post-COVID 19 era, with the increasing interest in traditional culture and government support for national cultural revival, we identify tremendous opportunities and potential in the cultural tourism sector. In response, we have developed strategic plans to establish a business presence in the culture tourism activities, acquiring cultural tourism construction projects, and offering planning and consultancy services for such initiatives. Once these key initiatives are established, we will lay the foundation for a comprehensive and integrated business model within this sector."
公司董事長兼首席執行官翁雪源先生評論說:「在中國國內旅遊市場的蓬勃增長中,尤其是在後COVID-19時代,隨着人們對傳統文化的興趣與日俱增,以及政府對民族文化復興的支持,我們發現了文旅領域的巨大機遇和潛力。作爲回應,我們制定了戰略計劃,在文化旅遊活動中建立業務基礎,收購文化旅遊建設項目,併爲此類舉措提供規劃和諮詢服務。一旦這些關鍵舉措確立,我們將爲該領域的全面綜合業務模式奠定基礎。」
Mr. Weng continued, "We believe the JV will fully leverage the strengths of each party involved. We bring commercial management expertise and diversified channels, while our partners, professors from Fudan University, offer deep academic resources and extensive experience in designing cultural tourism projects. By combining these strengths with favorable macroeconomic trends, we anticipate rapid growth in our cultural tourism business. Moreover, this investment aligns perfectly with our forthcoming strategy to build a cultural tourism group that will provide one-stop services, including the planning, design, construction, and operation of cultural tourism projects—which might be a unique offering in China's cultural tourism industry."
翁先生繼續說:「我們相信合資企業將充分利用所涉各方的優勢。我們帶來商業管理專業知識和多元化渠道,而我們的合作伙伴,復旦大學的教授,在設計文旅項目方面提供深厚的學術資源和豐富的經驗。通過將這些優勢與有利的宏觀經濟趨勢相結合,我們預計我們的文化旅遊業務將快速增長。此外,這項投資完全符合我們即將推出的建立文化旅遊集團的戰略,該集團將提供一站式服務,包括文化旅遊項目的規劃、設計、建設和運營——這可能是中國文旅行業中獨一無二的產品。」
About Golden Sun Health Technology Group Limited
關於金太陽健康科技集團有限公司
Established in 1997 and headquartered in Shanghai, China, Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited, is a provider of tutorial services in China with over twenty years of experience providing educational services that focus on the development of each of its student's strengths and potential, and the promotion of life-long skills and interests in learning. Golden Sun has three tutorial centers, one educational company that partners with high schools to offer language classes, and one logistics company that provides logistic and consulting services. The tutorial centers of Golden Sun focus on different groups of targeted students by offering different tutorial programs. For more information, visit the Company's website at ir.jtyjyjt.com.
金太陽健康科技集團有限公司(前身爲金太陽教育集團有限公司)成立於1997年,總部位於中國上海,是中國補習服務提供商,在提供教育服務方面擁有二十多年的經驗,這些教育服務側重於發展每個學生的優勢和潛力,並促進終身學習技能和興趣。Golden Sun有三個補習中心,一家與高中合作提供語言課程的教育公司,以及一家提供物流和諮詢服務的物流公司。Golden Sun的補習中心通過提供不同的補習計劃,專注於不同的目標學生群體。欲了解更多信息,請訪問該公司的網站ir.jtyjyjt.com。
Forward-Looking Statements
前瞻性陳述
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "approximates," "assesses," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may" or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's annual report and other filings with the U.S. Securities and Exchange Commission.
本公告中的某些陳述是前瞻性陳述。這些前瞻性陳述涉及已知和未知的風險和不確定性,基於公司當前對未來事件的預期和預測,公司認爲這些預期和預測可能會影響其財務狀況、經營業績、業務戰略和財務需求。投資者可以通過諸如 「近似」、「評估」、「相信」、「希望」、「期望」、「預期」、「預期」、「估計」、「項目」、「打算」、「計劃」、「將」、「將」、「應該」、「可能」、「可能」 或類似的表述來識別這些前瞻性陳述。除非法律要求,否則公司沒有義務公開更新或修改任何前瞻性陳述以反映隨後發生的事件或情況或預期的變化。儘管公司認爲這些前瞻性陳述中表達的預期是合理的,但它無法向您保證此類預期是正確的。公司提醒投資者,實際業績可能與預期業績存在重大差異,並鼓勵投資者在公司的年度報告和向美國證券交易委員會提交的其他文件中審查可能影響其未來業績的其他因素。
For more information, please contact:
欲了解更多信息,請聯繫:
Golden Sun Health Technology Group Limited
Investor Relations Department
Email: ir@cngsun.com
金太陽健康科技集團有限公司
投資者關係部
電子郵件:ir@cngsun.com
Ascent Investor Relations LLC
Tina Xiao
President
Phone: +1 646-932-7242
Email: investors@ascent-ir.com
Ascent 投資者關係有限責任公司
蒂娜肖
主席
電話:+1 646-932-7242
電子郵件:investors@ascent-ir.com